Skip to content
44

omeprazol

Skip it

Soft demand (-15.0% this quarter) — this niche doesn't clear our bar today.

Market size 42Growth 17Conversion 98Competition 18Returns 100Price range 42Avg price 38Brand share 25Review moat 76Quality gap 20

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Incredible17.2%

search→purchase rate — share of searches ending in a sale

Review moat

Great481.23

avg incumbent reviews — the moat a new listing must climb

Market size

Okay€221K

€221K/yr · 123K searches

Price range

Okay€5.45–€21.83

cheapest to priciest tracked listing — scored on the share inside $15–$100

Avg price

Okay€10.51

avg listing price — sweet spot $15–$100

Brand share

Bad90%

top-5 brand share — brand-locked demand

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Competition

Bad78%

top-5 click share — a locked-up shelf

Growth

Bad-15.0%

90-day search growth — must beat 0% to launch

Competition

The top 5 products capture 78% of clicks — a locked-up shelf that new listings rarely crack.

Brands

9 falling

Sellers

24

Top-5 brand share

90%

Open market

6%

  • Heumann27%
  • Zentiva26%
  • ratiopharm14%
  • apo-discounter.de12%
  • 1A PHARMA11%
  • vitenda4%
  • Open — no brand owns it (3 brands, 6%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%€22K20%€44K30%€66K40%€88K101001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 13 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — -15.0% search growth over the last 90 days.
3K2KSpike '24Prime Day '25SepDecMarJunAugNovMarMay

No pronounced peak months · busiest ÷ quietest = 1.2×

Reviews

What buyers praise and complain about, mined from review topics.

What buyers complain about

Dosierung100%

“und man wird abhängig und braucht immer höhere Dosis”